A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : TTR

Search Conditions:
Search Keyword : TTR
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: TTR
Appearance Frequency: 3327 time(s)
Long forms: 225

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
transthyretin
(2018 times)
Biochemistry
(447 times)
FAP (338 times)
RBP (132 times)
ATTR (81 times)
1984 Immunocytochemical studies on the localization of plasma and of cellular retinol-binding proteins and of transthyretin (prealbumin) in rat liver and kidney.
therapeutic range
(514 times)
Vascular Diseases
(117 times)
INR (200 times)
AF (136 times)
VKA (61 times)
2006 Worldwide management of oral anticoagulant therapy: the ISAM study.
time to recurrence
(250 times)
Neoplasms
(145 times)
OS (165 times)
HCC (72 times)
HR (42 times)
1993 Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients.
time to relapse
(53 times)
Neoplasms
(24 times)
OS (22 times)
NSCLC (8 times)
AML (5 times)
1989 LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.
time to response
(44 times)
Neoplasms
(24 times)
ORR (21 times)
DOR (20 times)
PFS (19 times)
1981 Relationship between time to treatment failure and survival and between time to response and response duration in metastatic breast cancer. Implications for treatment.
wild-type transthyretin
(21 times)
Cardiology
(4 times)
SSA (7 times)
FAP (3 times)
HFpEF (2 times)
1996 Structure of the Val122Ile variant transthyretin - a cardiomyopathic mutant.
time to tumor recurrence
(19 times)
Neoplasms
(11 times)
OS (10 times)
HR (7 times)
CI (5 times)
2008 Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer.
time to results
(18 times)
Microbiology
(9 times)
AST (3 times)
CI (2 times)
DST (2 times)
2002 Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix Automated Microbiology System.
time-in-therapeutic range
(14 times)
Vascular Diseases
(11 times)
AF (4 times)
INR (3 times)
ACR (1 time)
2004 Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range.
10  tracer-to-tracee ratio
(12 times)
Physiology
(4 times)
EGP (2 times)
GC/MS (2 times)
IVGTT (2 times)
1997 Measurement of very low stable isotope enrichments by gas chromatography/mass spectrometry: application to measurement of muscle protein synthesis.
11  thermotolerance ratio
(11 times)
Neoplasms
(6 times)
CHM (2 times)
PUR (2 times)
SUH (1 time)
1984 Heat sensitivity and thermotolerance in cells from five human melanoma xenografts.
12  transthyretin gene
(11 times)
Nervous System Diseases
(2 times)
AAO (1 time)
ATTR (1 time)
BCVA (1 time)
2009 Transthyretin gene (TTR) intron 1 elucidates crocodylian phylogenetic relationships.
13  type-token ratio
(10 times)
Speech-Language Pathology
(3 times)
MLUw (2 times)
BG (1 time)
BNT (1 time)
1981 Formal thought disorder, the type-token ratio and disturbed voluntary motor movement in schizophrenia.
14  time to resolution
(9 times)
Neoplasms
(7 times)
sTRAEs (3 times)
TTO (3 times)
IMM (2 times)
2014 Neighborhood factors associated with time to resolution following an abnormal breast or cervical cancer screening test.
15  target therapeutic range
(8 times)
Vascular Diseases
(3 times)
INR (3 times)
AF (2 times)
CI (1 time)
2003 Acenocoumarol therapy in pediatric patients.
16  tear turnover rate
(8 times)
Ophthalmology
(6 times)
ADDE (2 times)
EDE (2 times)
bTTR (1 time)
2001 An improved fluorophotometric method for tear turnover assessment.
17  time to recovery
(8 times)
Kidney Diseases
(1 time)
HD (2 times)
AUCs (1 time)
BDA (1 time)
1997 The prediction of length of major depressive episodes: results from an epidemiological sample of female twins.
18  anti-transthyretin
(7 times)
Neurology
(4 times)
AAV (1 time)
AD (1 time)
bGH (1 time)
1993 Immunoassay for transthyretin variants associated with amyloid neuropathy.
19  type transthyretin
(7 times)
Biochemistry
(2 times)
AgRP (1 time)
CAGE (1 time)
DEGs (1 time)
2008 Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture.
20  target range
(6 times)
Vascular Diseases
(3 times)
AF (2 times)
INR (2 times)
AC (1 time)
2000 Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management.
21  transporter transthyretin
(5 times)
Environmental Health
(2 times)
PBDEs (2 times)
AD (1 time)
AR (1 time)
2002 Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and chlorinated paraffins (CPs) in rats-testing interactions and mechanisms for thyroid hormone effects.
22  transthyretin-related
(5 times)
Biochemistry
(1 time)
AL (2 times)
AC (1 time)
ASCT (1 time)
2005 Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation.
23  RBP-transthyretin
(4 times)
Biochemistry
(3 times)
RBP (3 times)
Ito (1 time)
mAbs (1 time)
1991 Regulation of retinol uptake and esterification in MCF-7 and HepG2 cells by exogenous fatty acids.
24  Tabtoxin resistance protein
(4 times)
Molecular Biology
(2 times)
AcCoA (2 times)
GNAT (1 time)
HATs (1 time)
2001 Crystallization and preliminary X-ray crystallographic analysis of native and selenomethionyl recombinant tabtoxin-resistance protein complexed with acetyl-coenzyme A.
25  time to first recurrence
(4 times)
Neoplasms
(4 times)
OS (2 times)
EHC (1 time)
GBC (1 time)
2010 The prognostic value of tumor mitotic rate and other clinicopathologic factors in patients with locoregional recurrences of melanoma.
26  time to readmission
(4 times)
General Surgery
(2 times)
CI (1 time)
ES (1 time)
HF (1 time)
2014 Time-to-readmission and Mortality After High-risk Surgery.
27  time-to-retreatment
(4 times)
Neoplasms
(2 times)
CLL (2 times)
OS (2 times)
PFS (2 times)
2008 Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration.
28  transition temperature range
(4 times)
Dentistry
(3 times)
DSC (2 times)
Af (1 time)
Ms (1 time)
1980 A clinical trial of alignment of teeth using a 0.019 inch thermal nitinol wire with a transition temperature range between 31 degrees C. and 45 degrees C.
29  translation regulatory
(4 times)
Molecular Biology
(1 time)
RBPs (3 times)
DSRBPs (1 time)
NF90 (1 time)
2007 Analysis of turnover and translation regulatory RNA-binding protein expression through binding to cognate mRNAs.
30  targeting transthyretin
(3 times)
Chemistry
(1 time)
1,5-AmNS (1 time)
1,8-ANS (1 time)
siRNA (1 time)
2009 Identification of a novel ligand binding motif in the transthyretin channel.
31  TBG, transthyretin
(3 times)
Molecular Biology
(1 time)
TBG (2 times)
ACT (1 time)
AT (1 time)
1992 Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (Hep G2) cells.
32  tetrameric transthyretin
(3 times)
Chemistry Techniques, Analytical
(1 time)
FAP (1 time)
SSA (1 time)
2005 Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors.
33  tetrathionate reductase
(3 times)
Microbiology
(2 times)
TSO (2 times)
TSR (1 time)
1980 Thiosulfate Oxidation and Tetrathionate Reduction by Intact Cells of Marine Pseudomonad Strain 16B.
34  therapeutic International Normalized Ratio range
(3 times)
Thrombosis
(1 time)
ACTS (1 time)
AF (1 time)
RE-LY (1 time)
2010 Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA).
35  tibiotalar ratio
(3 times)
Orthopedics
(3 times)
TTS (1 time)
2016 Talolisthesis in end stage ankle arthrosis.
36  time-to-repeat
(3 times)
Endocrinology
(2 times)
CBG (1 time)
ICU (1 time)
IMC (1 time)
2016 Is all hypoglycaemia treated as equal? An observational study of how the type of diabetes and treatment prescribed prior to admission influences quality of treatment of inpatient hypoglycaemia.
37  transcriptional termination region
(3 times)
Clinical Laboratory Techniques
(1 time)
CGIs (1 time)
DME-like (1 time)
nc (1 time)
2008 Genetic heterogeneity of the dnaK gene locus including transcription terminator region (TTR) in Campylobacter lari.
38  transient thermoreflectance
(3 times)
Biophysics
(3 times)
FDTR (1 time)
2008 Pulse accumulation, radial heat conduction, and anisotropic thermal conductivity in pump-probe transient thermoreflectance.
39  Trauma Triage Rule
(3 times)
Emergency Medicine
(3 times)
--- 1992 Comparative performance of the Baxt Trauma Triage Rule.
40  true three-dimensional reconstruction
(3 times)
Diagnostic Imaging
(2 times)
ETTR (1 time)
TTCR (1 time)
1983 True Three-Dimensional Reconstruction (TTR) Application of Algorithm toward Full Utilization of Oblique Rays.
41  TH transport proteins, transthyretin
(2 times)
Environmental Health
(1 time)
Cl-PFAESs (1 time)
PFASs (1 time)
PFOS (1 time)
2016 Binding interactions of perfluoroalkyl substances with thyroid hormone transport proteins and potential toxicological implications.
42  therapeutic range of INR
(2 times)
Medicine
(1 time)
ADI (1 time)
OAC (1 time)
SES (1 time)
2012 The influence of VKORC1 and CYP2C9 gene sequence variants on the stability of maintenance phase warfarin treatment.
43  Thoracic Tumor Registry
(2 times)
Science
(1 time)
CT (1 time)
NSCLC (1 time)
SCLC (1 time)
2019 Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study).
44  Thyro-thymic thyroid rests
(2 times)
Family Practice
(1 time)
PT (1 time)
TSH (1 time)
TT (1 time)
2015 Non-elevation of TSH after total thyroidectomy: a surgical surprise.
45  thyroglossal tract remnant
(2 times)
Dentistry
(1 time)
--- 2007 Thyroglossal duct cyst: personal experience and literature review.
46  thyroxine transport protein transthyretin
(2 times)
Toxicology
(1 time)
--- 2006 Hydroxylated polychlorinated biphenyls (OH-PCBs): recent advances in wildlife contamination study.
47  tibiotarsal rotation
(2 times)
Veterinary Medicine
(2 times)
--- 1998 Factors on farms in eastern Australia associated with the development of tibiotarsal rotation in ostrich chicks.
48  time from initial diagnosis to relapse
(2 times)
Neoplasms
(1 time)
ALC-R (1 time)
DLBCL (1 time)
IPI-R (1 time)
2008 Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem cell transplantation.
49  time to local recurrence
(2 times)
Neoplasms
(2 times)
OS (1 time)
TTLiR (1 time)
TTM (1 time)
2009 Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs.
50  time to reperfusion
(2 times)
Environmental Health
(1 time)
MT (2 times)
AC (1 time)
AIS (1 time)
2019 Outcome, efficacy and safety of endovascular thrombectomy in ischaemic stroke according to time to reperfusion: data from a multicentre registry.
51  time to RT
(2 times)
Obstetrics
(1 time)
EC (1 time)
IC (1 time)
NPC (1 time)
2020 Impact of time to radiation therapy in adjuvant settings in endometrial carcinoma: A multicentric retrospective study.
52  time to tumour response
(2 times)
Pharmacology
(1 time)
PFS (2 times)
CK (1 time)
CR (1 time)
2013 Sunitinib objective response in metastatic renal cell carcinoma: analysis of 1059 patients treated on clinical trials.
53  total thermal response
(2 times)
Neurology
(2 times)
DA (2 times)
GFAP (2 times)
CP (1 time)
1998 Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response.
54  transthoracic resistance
(2 times)
Cardiology
(2 times)
TMR (1 time)
VF (1 time)
1981 Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure.
55  Transthyretin amyloid
(2 times)
Cardiovascular Diseases
(1 time)
AA (1 time)
FMF (1 time)
SAA (1 time)
2003 From renal amyloid deposits to the identification of the culprit genes.
56  transthyretin precursor
(2 times)
Proteome
(1 time)
6-PDGH (1 time)
AAT (1 time)
Apo J (1 time)
2008 Fine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers.
57  transthyretin protein
(2 times)
Genetics, Medical
(1 time)
FAP (2 times)
BEI (1 time)
CBS (1 time)
2011 Retrospective Mapping of SAR Data for TTR Protein in Chemico-Biological Space Using Ligand Efficiency Indices as a Guide to Drug Discovery Strategies.
58  transthyretin-bound
(2 times)
Chemistry, Clinical
(1 time)
RBP (2 times)
holo (1 time)
1990 Use of free and transthyretin-bound retinol-binding protein in serum as tests of vitamin A status in humans: effect of high creatinine concentrations in serum.
59  transverse transmission/reflection
(2 times)
Ophthalmology
(2 times)
ARROW (1 time)
MIM (1 time)
2009 Attenuation and mode profile determination of leaky/lossy modes in multilayer planar waveguides by a coupling simulation method.
60  treatment required
(2 times)
Gastroenterology
(1 time)
CS (1 time)
FL (1 time)
LTB (1 time)
2015 The role of "watch and wait" in intestinal follicular lymphoma in rituximab era.
61  triceps tendon ruptures
(2 times)
Wounds and Injuries
(1 time)
DKS (1 time)
2015 Functional outcomes and complications after surgical repair of triceps tendon rupture.
62  Tumour Tissue Repository
(2 times)
Preservation, Biological
(2 times)
BC (1 time)
GI (1 time)
PTC (1 time)
2014 Impact of a Permission to Contact (PTC) platform on biobank enrollment and efficiency.
63  turnover rate
(2 times)
Ophthalmology
(1 time)
ADDE (1 time)
EDE (1 time)
ROC (1 time)
2009 Tear physiology of aqueous deficiency and evaporative dry eye.
64  fat-to-total fat ratio
(1 time)
Hormones
(1 time)
BMI (1 time)
LATR (1 time)
LM (1 time)
2016 Relationship of lean mass and obesity in Indian urban children and adolescents.
65  H2-treatment temperature
(1 time)
Chemistry
(1 time)
--- 2018 On the origin of high-temperature phenomena in Pt/Al2O3.
66  Met30-transthyretin
(1 time)
Genetics, Medical
(1 time)
FAP (1 time)
1998 A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy.
67  mRNA--transthyretin
(1 time)
Science
(1 time)
AAT (1 time)
AFP (1 time)
ALB (1 time)
2006 In vitro differentiation of mouse ES cells into hepatocytes with coagulation factors VIII and IX expression profiles.
68  N-terminal region of transthyretin
(1 time)
Biochemistry
(1 time)
RBP (1 time)
THs (1 time)
2011 Effect of the N-terminal sequence on the binding affinity of transthyretin for human retinol-binding protein.
69  re-treatment
(1 time)
Hematology
(1 time)
CLL (1 time)
CR (1 time)
FC (1 time)
2010 Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome.
70  T-tube repair
(1 time)
Gastroenterology
(1 time)
BDIs (1 time)
CJ (1 time)
ERC (1 time)
2008 Iatrogenic biliary injury: 13,305 cholecystectomies experienced by a single surgical team over more than 13 years.
71  T. trifolii resistance
(1 time)
Chemistry
(1 time)
AKR (1 time)
APR (1 time)
2020 Ethylene Is Not Essential for R-Gene Mediated Resistance but Negatively Regulates Moderate Resistance to Some Aphids in Medicago truncatula.
72  table-top autorefractor
(1 time)
Eye Diseases
(1 time)
CV (1 time)
Rmax (1 time)
SEV (1 time)
2014 Comparison of the Retinomax hand-held autorefractor versus table-top autorefractor and retinoscopy.
73  tafamidis to ameliorate transthyretin
(1 time)
Biochemistry
(1 time)
--- 2015 Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy).
74  tafamidis treatment on transthyretin
(1 time)
Neurology
(1 time)
AEs (1 time)
mBMI (1 time)
NIS-LL (1 time)
2016 Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study.
75  tailored telescopic reconstruction
(1 time)
Transplantation
(1 time)
cDDRs (1 time)
DDR (1 time)
LDLT (1 time)
2010 Tailored telescopic reconstruction of the bile duct in living donor liver transplantation.
76  Talent Thoracic Retrospective Registry
(1 time)
General Surgery
(1 time)
--- 2008 Emergency treatment of the thoracic aorta: results in 113 consecutive acute patients (the Talent Thoracic Retrospective Registry).
77  tandem tetranucleotide repeat
(1 time)
Genetics
(1 time)
CF (1 time)
CFTR (1 time)
2002 [Analysis of the spectra of mutations and polymorphic loci of cystic fibrosis transmembrane conductance regulator in the population of Bashkortostan].
78  Tangtong Recipe
(1 time)
Complementary Therapies
(1 time)
VSMCs (1 time)
2009 [Effect of tangtong recipe on the proliferation of cultured iliac arterial smooth muscle cells of diabetic rats in vitro].
79  target INR
(1 time)
Pharmacology
(1 time)
AF (1 time)
GP (1 time)
INR (1 time)
2016 Impact of age on long-term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient management.
80  target INR range
(1 time)
Drug Therapy
(1 time)
INR (1 time)
PEFS (1 time)
TER (1 time)
2019 Impact of a pharmacist-led education and follow-up service on anticoagulation control and safety outcomes at a tertiary hospital in China: a randomised controlled trial.
81  target international normalised ratio range
(1 time)
Medicine
(1 time)
AF (1 time)
VKAs (1 time)
VTE (1 time)
2014 Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review.
82  target PRU ranges
(1 time)
Neurology
(1 time)
SAC (1 time)
2021 Active management of the target P2Y12 reaction unit range in patients undergoing stent-assisted coil embolization for unruptured cerebral aneurysms.
83  target transthyretin gene
(1 time)
Drug Therapy
(1 time)
ATTR (1 time)
EMA (1 time)
FDA (1 time)
2019 Patisiran for the treatment of patients with familial amyloid polyneuropathy.
84  target tumour response
(1 time)
Radiology
(1 time)
GIST (1 time)
2005 Follow-up of gastro-intestinal stromal tumours (GIST) during treatment with imatinib mesylate by abdominal MRI.
85  targeted therapy resistance
(1 time)
Neoplasms
(1 time)
CSCs (1 time)
TT (1 time)
2016 At the crossroads of cancer stem cells and targeted therapy resistance.
86  tarsal tunnel release
(1 time)
General Surgery
(1 time)
PNR (1 time)
SFI (1 time)
SSEP (1 time)
2007 Effect of early nerve release on the progression of neuropathy in diabetic rats.
87  taurultame-taurinamide ratio
(1 time)
Pharmacology
(1 time)
HPLC (1 time)
2007 Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients.
88  taxa-time relationship
(1 time)
Science
(1 time)
CCA (1 time)
DO (1 time)
2014 Bacterial community dynamics and taxa-time relationships within two activated sludge bioreactors.
89  TBPA then was renamed transthyretin
(1 time)
Clinical Laboratory Techniques
(1 time)
RBP (1 time)
TBPA (1 time)
2003 Transthyretin from discovery to now.
90  tectoridin
(1 time)
Pharmacology
(1 time)
JSRVs (1 time)
RyR (1 time)
2000 Tectoridins modulate skeletal and cardiac muscle sarcoplasmic reticulum calcium-release channels.
91  Tectorigenin
(1 time)
Complementary Therapies
(1 time)
MRSA (1 time)
PGN (1 time)
TEM (1 time)
2014 The Antibacterial Assay of Tectorigenin with Detergents or ATPase Inhibitors against Methicillin-Resistant Staphylococcus aureus.
92  telehealth technology related
(1 time)
Medical Informatics
(1 time)
ATP (1 time)
OSMT (1 time)
2021 An Ostomy Self-management Telehealth Intervention for Cancer Survivors: Technology-Related Findings From a Randomized Controlled Trial.
93  temperature rise
(1 time)
Anthropology, Physical
(1 time)
BD (1 time)
CIVD (1 time)
JP (1 time)
2016 Cold-induced vasodilation comparison between Bangladeshi and Japanese natives.
94  temperature transition range
(1 time)
Dentistry
(1 time)
--- 1979 55 Nitinol wire: force developed as a function of "elastic memory".
95  tendon ruptures
(1 time)
Orthopedics
(1 time)
QTR (1 time)
2018 Simultaneous Ipsilateral Quadriceps and Triceps Tendon Rupture in a Patient with End-Stage Renal Failure.
96  tendon tap response
(1 time)
Rehabilitation
(1 time)
DTR (1 time)
2012 Position-dependent, hyperexcitable patellar reflex dynamics in chronic stroke.
97  tension to rupture
(1 time)
Toxicology
(1 time)
DXR (1 time)
ECG (1 time)
TSNIIA-SS (1 time)
2009 Tanshinone IIA sodium sulfonate protects against cardiotoxicity induced by doxorubicin in vitro and in vivo.
98  test for significance performed on log
(1 time)
Endocrinology
(1 time)
CBG (1 time)
2016 Is all hypoglycaemia treated as equal? An observational study of how the type of diabetes and treatment prescribed prior to admission influences quality of treatment of inpatient hypoglycaemia.
99  test their effect on transthyretin
(1 time)
Biochemistry
(1 time)
EGCG (1 time)
FAP (1 time)
GI (1 time)
2012 Natural polyphenols as modulators of TTR amyloidogenesis: in vitro and in vivo evidences towards therapy.
100  testosterone
(1 time)
Environmental Health
(1 time)
17-HPT (1 time)
17beta-HSD (1 time)
ADD (1 time)
2011 Modulation of estrogen synthesis through activation of protein kinase A in H295R cells by extracts of estuary sediments.